ATE290093T1 - EXPRIMIERUNG EINES MODIFIZIERTEM ßFOAMY VIRUS ENVELOPE PROTEINß (HÜLLENPROTEIN) - Google Patents

EXPRIMIERUNG EINES MODIFIZIERTEM ßFOAMY VIRUS ENVELOPE PROTEINß (HÜLLENPROTEIN)

Info

Publication number
ATE290093T1
ATE290093T1 AT98905562T AT98905562T ATE290093T1 AT E290093 T1 ATE290093 T1 AT E290093T1 AT 98905562 T AT98905562 T AT 98905562T AT 98905562 T AT98905562 T AT 98905562T AT E290093 T1 ATE290093 T1 AT E290093T1
Authority
AT
Austria
Prior art keywords
modified
ßfoamy
proteinß
expressing
virus envelope
Prior art date
Application number
AT98905562T
Other languages
English (en)
Inventor
Axel Rethwilm
Dirk Lindemann
Arend Jan Winter
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE290093T1 publication Critical patent/ATE290093T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17051—Methods of production or purification of viral material
    • C12N2740/17052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98905562T 1997-03-13 1998-03-13 EXPRIMIERUNG EINES MODIFIZIERTEM ßFOAMY VIRUS ENVELOPE PROTEINß (HÜLLENPROTEIN) ATE290093T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 2199989 CA2199989A1 (en) 1997-03-13 1997-03-13 Expression of a foamy virus envelope protein
PCT/IB1998/000343 WO1998040507A1 (en) 1997-03-13 1998-03-13 Expression of a modified foamy virus envelope protein

Publications (1)

Publication Number Publication Date
ATE290093T1 true ATE290093T1 (de) 2005-03-15

Family

ID=4160166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98905562T ATE290093T1 (de) 1997-03-13 1998-03-13 EXPRIMIERUNG EINES MODIFIZIERTEM ßFOAMY VIRUS ENVELOPE PROTEINß (HÜLLENPROTEIN)

Country Status (8)

Country Link
EP (1) EP0977881B1 (de)
JP (1) JP2001514517A (de)
AT (1) ATE290093T1 (de)
AU (1) AU733948B2 (de)
CA (1) CA2199989A1 (de)
DE (1) DE69829174T2 (de)
ES (1) ES2236888T3 (de)
WO (1) WO1998040507A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309071B2 (en) 2008-06-27 2012-11-13 Vectoria Forschungsforderungs Verein E.V. Foamy viral envelope genes
KR20230065640A (ko) * 2021-11-05 2023-05-12 중앙대학교 산학협력단 2-플라스미드 시스템으로 제조된 가짜 포미 바이러스 및 이의 용도

Also Published As

Publication number Publication date
AU6110698A (en) 1998-09-29
EP0977881B1 (de) 2005-03-02
CA2199989A1 (en) 1998-09-13
ES2236888T3 (es) 2005-07-16
WO1998040507A1 (en) 1998-09-17
AU733948B2 (en) 2001-05-31
DE69829174D1 (de) 2005-04-07
JP2001514517A (ja) 2001-09-11
DE69829174T2 (de) 2006-01-26
EP0977881A1 (de) 2000-02-09

Similar Documents

Publication Publication Date Title
ATE288489T1 (de) Vp-antigene des jc-virus
PT688227E (pt) Producao de proteina da capsula de papiloma humano e particulas semelhantes a virus
DE59410380D1 (de) Endosomolytisch wirksame partikel
JP2013213034A (ja) パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法
TW428026B (en) Bifunctional protein, preparation and use
UA85536C2 (en) Viral antigens
PT1012295E (pt) Sistemas de replicacoes de rna de alfavirus
FI964592A0 (fi) Papilloomavirusrokotteita
ATE472335T1 (de) Chimere alphavirus-replikon-partikel
DK1187928T3 (da) Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics
DE69734829D1 (de) Infektiöse pseudovirale papillomavirus partikel
CY1107431T1 (el) Σωματιδια για γoνιδιακη θεραπεια
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
ATE290093T1 (de) EXPRIMIERUNG EINES MODIFIZIERTEM ßFOAMY VIRUS ENVELOPE PROTEINß (HÜLLENPROTEIN)
AU3390995A (en) Novel implant and novel vector for the treatment of acquired diseases
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
WO1997004099A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
ES2187551T3 (es) Proteina l2 de papilomavirus modificada y vlps formadas a partir de la misma.
GB0216081D0 (en) Methods of making biological materials and uses thereof
WO1999042619A3 (en) Association of the serotonin transport (htt) gene with cardiovascular disease and longevity
ATE301721T1 (de) In vivo herstellung von replicativen molekülen
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
DE69728447D1 (de) Veränderte, kleine rna-viren
WO1999025837A3 (de) Verfahren zur gewinnung von virusähnlichen partikeln auf der basis von polyomaviren
PT870050E (pt) Virus que expressam proteinas toxicas e linhas de celulas produtoras

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0977881

Country of ref document: EP

REN Ceased due to non-payment of the annual fee